當(dāng)前位置：   首頁 > 需求大廳

 >  特色服務(wù) 

 >  信息服務(wù) 

利伐沙班最新歐洲藥典中對(duì)映異構(gòu)體所用的色譜柱的具體型號(hào)，及檢測方法。   [更多]

請(qǐng)求這個(gè)藥品的具體質(zhì)量指標(biāo)參數(shù)   [更多]

需要詳細(xì)的標(biāo)準(zhǔn)以及檢測方法，有跟其他國家的對(duì)比的更好   [更多]

標(biāo)題：重金求購Calcium gluconate for injection《EP10.2》、USP43、BP藥典標(biāo)準(zhǔn)一份 詳細(xì)要求：Calcium gluconate for injection《EP10.2》》、USP43、BP藥典標(biāo)準(zhǔn)各一份 交稿方式：直接點(diǎn)擊交稿在線交稿就是了，我會(huì)每天過來看的，謝謝各位藥智的戰(zhàn)友們   [更多]

藥品檢驗(yàn)參考。   [更多]

求購Aceclofenac《BP2019》或者《BP2020》的藥典標(biāo)準(zhǔn)一份 電子稿件或清晰的拍照照片均可   [更多]

文獻(xiàn)： 1、" Posaconazole as salvage therapy in a patient with disseminated zygomycosis: case report and review of the literature. " Pharmacotherapy 2007;27:290–8. Page RL, Schwiesow J, Hilts A. 2、Mucormycosis treated with posaconazole: review of 96 case reports. Crit Rev Microbiol 2013;39:310–24. Vehreschild JJ, Birtel A, Vehreschild MJGT, et al. 3、Tarantino MD, Fogarty P, Mayer B, Vasey SY, Brainsky A. Efficacy of eltrombopag in management of bleeding symptoms associated with chronic immune thrombocytopenia. Blood Coagul Fibrinolysis. 2013 Apr;24(3):284-96. doi: 10.1097/MBC.0b013e32835fac99. 4、J Med Chem, 51: 4632～4640. Org. Process Res. Dev. 2019, 23, 9, 2057-2068 Pharmazie 73(9):494-497 · September 2018 5、中國醫(yī)藥工業(yè)雜志 2012， 43（8）， 644-646 6、精細(xì)化工中間體2013，43（2），46-48 7、精細(xì)化工中間體2011，41（4），46-48 8、中國現(xiàn)代應(yīng)用藥學(xué)2011，28（1），58-59 9、Chemical biology&Drug Design 2014, 83(3), 306-316 10、Letters in organic chemistry 2012, 9(4), 276-279 11、Medicines Evidence Commentary : Chronic kidney disease: calcium-based versus non-calcium-based phosphate binders Source: National Institute for Health and Care Excellence - NICE - 21 January 2014 - Publisher: National Institute for Health and Care Excellence (NICE) 12、double-blind comparison of calcium chloride and calcium gluconate therapies for hypocalcemia in critically ill children 13、J. Med. Chem. 2018, 61, 5304?5322. 14、Chem. Biol. Drug Des. 2014, 83, 306?316. 15、J. Pharm. Biomed. Anal. 2009, 50, 144?150. 16、Int. J. Pharm. Sci. 2016, 8, 97?102. 17、J. Pharm. Biomed. Anal. 2010, 52, 493?507. 18、Org. Process Res. Dev. 2013, 17, 1036?1041. 19、Beilstein J. Org. Chem. 2011, 7, 442? 495. 20、Bioorg. Med. Chem. Lett. 2014, 24, 1108?1110. 21、New Activated PEG Derivatives for Affinity Partitioning 22、Population incidence and mortality of sepsis in an urban African setting 2013-2016 23、Association of the Quick Sequential (Sepsis-Related) Organ Failure Assessment (qSOFA) Score With Excess Hospital Mortality in   [更多]

1、Arzneimittelforschung. 1985;35(7A):1203-8. Ohashi S, Iwatani M, Hyakuna Y, Morioka Y. Thermographic evaluation of the hemodynamic effect of the antithrombotic drug cilostazol in peripheral arterial occlusion. 2、Arzneimittelforschung. 1985;35(7A):1149-54. K Kawamura, K Watanabe, Y Kimura. Effect of cilostazol, a new antithrombotic drug, on cerebral circulation 3、Gel formation of cefpodoxime proxetil 4、Gas chromatographic analysis of fosfomycin in plasma for pharmacokinetic analysis. GK Webster, RG Bell - Journal of AOAC International, 1999 - europepmc.org 5、Rydell N, Butler J, Balazs EA. Hyaluronic acid in synovial fluid.Ⅵ. Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of the arthritis in track horses. Acta Vet Scand, 1970,11:139~146 6、Peyron JG, Balazs EA. Preliminary clinical assessment of Na-hyaluronate injection into human arthritic joints. Pathol Biol, 1974, 22:731~736 7、Weiss C, Balazs EA, St Onge R, et al. Clinical studies of the intra-articular injection of Healon in the treatment of osteoarthritis of human knee. Semin Arhtritis Rheum, 1980, 11(Suppl 1):143~144 8、Punzi L, Schiavon F, Ramonda R, et al. Intra-articular hyaluronic acid in the treatment of inflammatory and non-inflammatory knee diffusions. Curr Ther Res, 1988, 43:643~647 9、Nolan JP, reducing Catheter Related Bacteraemia in Haemodialysis. Vascular Access Soc. 5th Int. Congress of Vascular Access Soc, Nice, 2007 10、Arzneimittelforschung. 1984;34(9):948-52. Iron derivatives of modified milk protein.   [更多]

MONOGRAPHS: Levofloxacin《USP43-NF38》的藥典標(biāo)準(zhǔn)一份 USP MONOGRAPHS: Levofloxacin Tablets《USP43-NF38》的藥典標(biāo)準(zhǔn)一份 Levofloxacin Tablets《USP–NF 2021(Issue 2)》的藥典標(biāo)準(zhǔn)一份 Levofloxacin《USP–NF 2021(Issue 2)》的藥典標(biāo)準(zhǔn)一份 左氧氟沙星、片藥品注冊(cè)標(biāo)準(zhǔn) Levofloxacin Fine Granules《JP17(英)》的藥典標(biāo)準(zhǔn)一份   [更多]

標(biāo)題：請(qǐng)人查關(guān)于Faropenem Sodium Hydrate《JP17(英)》及Faropenem Sodium Tablets《JP17(英)》的藥典標(biāo)準(zhǔn) 需求名稱：Faropenem Sodium Hydrate《JP17(英)》及Faropenem Sodium Tablets《JP17(英)》的藥典標(biāo)準(zhǔn) 價(jià)格預(yù)算：50元 需求時(shí)間：請(qǐng)?jiān)?020年11月28號(hào)之前提交 交稿方式：請(qǐng)將文獻(xiàn)直接打包在藥智網(wǎng)交稿就可以了   [更多]